Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Loreto Martinez-Gonzalez & Ana Martinez. (2023) Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 32:2, pages 141-160.
Read now
Read now
I. Giovannelli, P. Heath, P. J. Shaw & J. Kirby. (2020) The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 435-444.
Read now
Read now
Alberto Catanese, Florian Olde Heuvel, Medhanie Mulaw, Maria Demestre, Julia Higelin, Gotthold Barbi, Axel Freischmidt, Jochen H. Weishaupt, Albert C. Ludolph, Francesco Roselli & Tobias M. Boeckers. (2019) Retinoic acid worsens ATG10-dependent autophagy impairment in TBK1-mutant hiPSC-derived motoneurons through SQSTM1/p62 accumulation. Autophagy 15:10, pages 1719-1737.
Read now
Read now
Bing-Wen Soong & Chun-Fang Wu. (2015) Neurodegenerative diseases: From the bench to the clinic. Journal of Neurogenetics 29:2-3, pages 39-40.
Read now
Read now
Articles from other publishers (43)
Afshin Babazadeh, Stephanie L. Rayner, Albert Lee & Roger S. Chung. (2023) TDP-43 as a therapeutic target in neurodegenerative diseases: Focusing on motor neuron disease and frontotemporal dementia. Ageing Research Reviews 92, pages 102085.
Crossref
Crossref
Nicholas J. Maragakis, Mamede de Carvalho & Michael D. Weiss. (2023)
Therapeutic targeting of
ALS
pathways: Refocusing an incomplete picture
. Annals of Clinical and Translational Neurology 10:11, pages 1948-1971.
Crossref
Crossref
Luca Lo Piccolo, Takanari Umegawachi, Ranchana Yeewa, Saranyapin Potikanond, Wutigri Nimlamool, Virapong Prachayasittikul, Yusuke Gotoh, Hideki Yoshida, Masamitsu Yamaguchi & Salinee Jantrapirom. (2023) A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy. Neurotherapeutics 20:5, pages 1330-1346.
Crossref
Crossref
Jessica Mandrioli, Roberto D’Amico, Elisabetta Zucchi, Sara De Biasi, Federico Banchelli, Ilaria Martinelli, Cecilia Simonini, Domenico Lo Tartaro, Roberto Vicini, Nicola Fini, Giulia Gianferrari, Marcello Pinti, Christian Lunetta, Francesca Gerardi, Claudia Tarlarini, Letizia Mazzini, Fabiola De Marchi, Ada Scognamiglio, Gianni Sorarù, Andrea Fortuna, Giuseppe Lauria, Eleonora Dalla Bella, Claudia Caponnetto, Giuseppe Meo, Adriano Chio, Andrea Calvo & Andrea Cossarizza. (2023) Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis. Nature Communications 14:1.
Crossref
Crossref
Mira Seidel, Sandeep Rajkumar, Christina Steffke, Vivien Noeth, Shreya Agarwal, Kevin Roger, Joanna Lipecka, Albert Ludolph, Chiara Ida Guerrera, Tobias Boeckers & Alberto Catanese. (2023) Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD in vitro models. Current Research in Neurobiology 5, pages 100105.
Crossref
Crossref
Non-Nuoc Tran & Byung-Hoon Lee. (2022) Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
O. H. Houghton, S. Mizielinska & P. Gomez-Suaga. (2022) The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Sean S. Keating, Rebecca San Gil, Molly E.V. Swanson, Emma L. Scotter & Adam K. Walker. (2022) TDP-43 pathology: From noxious assembly to therapeutic removal. Progress in Neurobiology 211, pages 102229.
Crossref
Crossref
Liaisan Arslanbaeva & Marco Bisaglia. (2022) Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment. Molecules 27:5, pages 1471.
Crossref
Crossref
Qian Cai & Dhasarathan Ganesan. (2022) Regulation of neuronal autophagy and the implications in neurodegenerative diseases. Neurobiology of Disease 162, pages 105582.
Crossref
Crossref
Georgios Pampalakis, Georgios Angelis, Eleni Zingkou, Kostas Vekrellis & Georgia Sotiropoulou. (2022) A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis. Clinical and Translational Medicine 12:1.
Crossref
Crossref
Haibo Wang, Manohar Kodavati, Gavin W. Britz & Muralidhar L. Hegde. (2021) DNA Damage and Repair Deficiency in ALS/FTD-Associated Neurodegeneration: From Molecular Mechanisms to Therapeutic Implication. Frontiers in Molecular Neuroscience 14.
Crossref
Crossref
Julie Bastien, Suchithra Menon, Mirko Messa & Beat Nyfeler. (2021) Molecular targets and approaches to restore autophagy and lysosomal capacity in neurodegenerative disorders. Molecular Aspects of Medicine 82, pages 101018.
Crossref
Crossref
Francesco Liguori, Susanna Amadio & Cinzia Volonté. (2021) Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers. Cellular and Molecular Life Sciences 78:17-18, pages 6143-6160.
Crossref
Crossref
Michail S. Kukharsky, Veronika I. Skvortsova, Sergey O. Bachurin & Vladimir L. Buchman. (2020) In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches. Medicinal Research Reviews 41:5, pages 2804-2822.
Crossref
Crossref
Fabiola De Marchi, Ivana Munitic, Amedeo Amedei, James D. Berry, Eva L. Feldman, Eleonora Aronica, Giovanni Nardo, Donatienne Van Weehaeghe, Elena Niccolai, Nikolina Prtenjaca, Stacey A. Sakowski, Caterina Bendotti & Letizia Mazzini. (2021) Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact. Neuroscience & Biobehavioral Reviews 127, pages 958-978.
Crossref
Crossref
Jannigje Rachel Kok, Nelma M. Palminha, Cleide Dos Santos Souza, Sherif F. El-Khamisy & Laura Ferraiuolo. (2021) DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity. Cellular and Molecular Life Sciences 78:15, pages 5707-5729.
Crossref
Crossref
Francesco Liguori, Susanna Amadio & Cinzia Volonté. (2021) Where and Why Modeling Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 22:8, pages 3977.
Crossref
Crossref
Valle Palomo, Vanesa Nozal, Elisa Rojas‐Prats, Carmen Gil & Ana Martinez. (2020) Protein kinase inhibitors for amyotrophic lateral sclerosis therapy. British Journal of Pharmacology 178:6, pages 1316-1335.
Crossref
Crossref
Sophie Layalle, Laetitia They, Sarah Ourghani, Cédric Raoul & Laurent Soustelle. (2021) Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster. International Journal of Molecular Sciences 22:2, pages 904.
Crossref
Crossref
Waleska Kerllen Martins, Maryana do Nascimento da Silva, Kiran Pandey, Ikuko Maejima, Ercília Ramalho, Vania Claudia Olivon, Susana Nogueira Diniz & Daniel Grasso. (2021) Autophagy-targeted therapy to modulate age-related diseases: Success, pitfalls, and new directions. Current Research in Pharmacology and Drug Discovery 2, pages 100033.
Crossref
Crossref
Shinrye Lee, Younghwi Kwon, Seyeon Kim, Myungjin Jo, Yu-Mi Jeon, Mookyung Cheon, Seongsoo Lee, Sang Ryong Kim, Kiyoung Kim & Hyung-Jun Kim. (2020) The Role of HDAC6 in TDP-43-Induced Neurotoxicity and UPS Impairment. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Sonja K. Soo, Paige D. Rudich, Annika Traa, Namasthée Harris-Gauthier, Hazel J. Shields & Jeremy M. Van Raamsdonk. (2020) Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders. Mechanisms of Ageing and Development 190, pages 111297.
Crossref
Crossref
S.N. Suresh, Anushka Chakravorty, Mridhula Giridharan, Lakshmi Garimella & Ravi Manjithaya. (2020) Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases. Journal of Molecular Biology 432:8, pages 2822-2842.
Crossref
Crossref
Rebecca L. Casterton, Rachel J. Hunt & Manolis Fanto. (2020) Pathomechanism Heterogeneity in the Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disease Spectrum: Providing Focus Through the Lens of Autophagy. Journal of Molecular Biology 432:8, pages 2692-2713.
Crossref
Crossref
Jessica Mandrioli, Laura Mediani, Simon Alberti & Serena Carra. (2020) ALS and FTD: Where RNA metabolism meets protein quality control. Seminars in Cell & Developmental Biology 99, pages 183-192.
Crossref
Crossref
AdrianaDelice Foster & SarahLyn Rea. (2020) The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis. Neural Regeneration Research 15:12, pages 2186.
Crossref
Crossref
V. Pozzilli, F. Giona, M. Ceccanti, C. Cambieri, V. Frasca, E. Onesti, L. Libonati, S. Di Bari, I. Fiorini, L. Cardarelli, M. Santopietro & M. Inghilleri. (2019) A case of motor neuron involvement in Gaucher disease. Molecular Genetics and Metabolism Reports 21, pages 100540.
Crossref
Crossref
Myungjin Jo, Shinrye Lee, Kiyoung Kim, Seongsoo Lee, Sang Ryong Kim & Hyung-Jun Kim. (2019) Inhibition of MEK5 suppresses TDP-43 toxicity via the mTOR-independent activation of the autophagy-lysosome pathway. Biochemical and Biophysical Research Communications 513:4, pages 925-932.
Crossref
Crossref
Rudolf C Hergesheimer, Anna A. Chami, Denis Reis de Assis, Patrick Vourc’h, Christian R. Andres, Philippe Corcia, Débora Lanznaster & Hélène Blasco. (2019) The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?. Brain 142:5, pages 1176-1194.
Crossref
Crossref
Dao K.H. Nguyen, Ravi Thombre & Jiou Wang. (2019) Autophagy as a common pathway in amyotrophic lateral sclerosis. Neuroscience Letters 697, pages 34-48.
Crossref
Crossref
Valle Palomo, Carlota Tosat-Bitrian, Vanesa Nozal, Siranjeevi Nagaraj, Angeles Martin-Requero & Ana Martinez. (2019) TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis. ACS Chemical Neuroscience 10:3, pages 1183-1196.
Crossref
Crossref
Jaiprakash SharmaAlberto di RonzaParisa LotfiMarco Sardiello. (2018) Lysosomes and Brain Health. Annual Review of Neuroscience 41:1, pages 255-276.
Crossref
Crossref
Jessica Mandrioli, Roberto D’Amico, Elisabetta Zucchi, Annalisa Gessani, Nicola Fini, Antonio Fasano, Claudia Caponnetto, Adriano Chiò, Eleonora Dalla Bella, Christian Lunetta, Letizia Mazzini, Kalliopi Marinou, Gianni Sorarù, Sara de Biasi, Domenico Lo Tartaro, Marcello Pinti & Andrea Cossarizza. (2018) Rapamycin treatment for amyotrophic lateral sclerosis. Medicine 97:24, pages e11119.
Crossref
Crossref
Teresa Niccoli, Linda Partridge & Adrian M. Isaacs. (2017) Ageing as a risk factor for ALS/FTD. Human Molecular Genetics 26:R2, pages R105-R113.
Crossref
Crossref
Eline Wauters, Sara Van Mossevelde, Julie Van der Zee, Marc Cruts & Christine Van Broeckhoven. (2017) Modifiers of GRN -Associated Frontotemporal Lobar Degeneration. Trends in Molecular Medicine 23:10, pages 962-979.
Crossref
Crossref
Nandini Ramesh & Udai Bhan Pandey. (2017) Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Jer-Cherng Chang & David B. Morton. (2017) Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects. PLOS ONE 12:7, pages e0180828.
Crossref
Crossref
M. Collins & R. Bowser. 2017. Molecular and Cellular Therapies for Motor Neuron Diseases. Molecular and Cellular Therapies for Motor Neuron Diseases
61
99
.
Vincent Picher-Martel, Paul N. Valdmanis, Peter V. Gould, Jean-Pierre Julien & Nicolas Dupré. (2016) From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta Neuropathologica Communications 4:1.
Crossref
Crossref
Kerri J. Kinghorn, Sebastian Grönke, Jorge Iván Castillo-Quan, Nathaniel S. Woodling, Li Li, Ernestas Sirka, Matthew Gegg, Kevin Mills, John Hardy, Ivana Bjedov & Linda Partridge. (2016)
A
Drosophila
Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin
. The Journal of Neuroscience 36:46, pages 11654-11670.
Crossref
Crossref
Zachary Monahan, Frank Shewmaker & Udai Bhan Pandey. (2016) Stress granules at the intersection of autophagy and ALS. Brain Research 1649, pages 189-200.
Crossref
Crossref
Gianfranco Natale, Paola Lenzi, Gloria Lazzeri, Alessandra Falleni, Francesca Biagioni, Larisa Ryskalin & Francesco Fornai. (2015) Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesis. Frontiers in Cellular Neuroscience 9.
Crossref
Crossref